MedPath

An observational study to evaluate drug utilization pattern and adverse drug reaction profile in radiotherapy and oncology section.

Phase 4
Conditions
Health Condition 1: null- Adverse drug reaction profile and drug utilization pattern in radiotherapy and oncology section.
Registration Number
CTRI/2016/11/007421
Lead Sponsor
Department of Pharmacology Government Medical College Bhavnagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

1.All the participants undergoing chemotherapy in day care centre during the study time period will be enrolled.

2.All participants receiving anti-cancer regimens, will be included in the study .

ï?§3.Participants of any age group

Exclusion Criteria

Patients not receiving any kind of cancer chemotherapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢To analyze drug utilization pattern. <br/ ><br>â?¢To identify the ADRâ??s caused by anti-cancer drugs <br/ ><br>Timepoint: In morning OPD hours and in evening round ( 3days per week)for 2 year duration.
Secondary Outcome Measures
NameTimeMethod
<br/ ><br>â?¢Information of patient like name, age, gender, weight, and address of patient. <br/ ><br>â?¢Information of drug, its dose, dosage form, mode of administration and total duration of therapy. <br/ ><br>â?¢Treatment according to STG( Standard treatment guidelines) or not. <br/ ><br>â?¢To determine ADRs due to multidrug anticancer regimens <br/ ><br>and to evaluate its causality , severity, preventability, <br/ ><br>whether it is reversible or irreversible and to study drug utilization pattern in cancer patients. <br/ ><br>Timepoint: In morning OPD hours and in evening round ( 3days per week)for 2 year duration.
© Copyright 2025. All Rights Reserved by MedPath